Search
Balipodect
go.drugbank.com/drugs/DB14774InvestigationalBalipodect is under investigation in clinical trial NCT01892189 (Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults).
NADH
go.drugbank.com/drugs/DB00157ApprovedNutraceuticalIt is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH).
Relebactam
go.drugbank.com/drugs/DB12377ApprovedInvestigational[label] It is considered to be a last-line treatment option and gained FDA approval as part of the combination product RecarbrioⓇ in July 2019.[L7568]
Iopofosine I-131
go.drugbank.com/drugs/DB15244InvestigationalIopofosine I-131 (NM-404 I-131) is under investigation in clinical trial NCT01495663 (Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned).
Zodasiran
go.drugbank.com/drugs/DB17626InvestigationalIt was granted an orphan drug designation for the treatment of homozygous familial hypercholesterolemia (HoFH).[L45869]
Cry5B
go.drugbank.com/drugs/DB17783ExperimentalWith demonstrated anthelmintic properties, it has been investigated in the treatment of parasitic intestinal infections.[A259372, A259377]
Limnetrelvir
go.drugbank.com/drugs/DB21677ExperimentalLimnetrelvir has a monoisotopic molecular weight of 557.17 Da.
Epsametostat
go.drugbank.com/drugs/DB21726ExperimentalEpsametostat has a monoisotopic molecular weight of 611.28 Da.
Enerisant
go.drugbank.com/drugs/DB20605ExperimentalEnerisant has a monoisotopic molecular weight of 398.23 Da.
Levolansoprazole
go.drugbank.com/drugs/DB20673ExperimentalLevolansoprazole has a monoisotopic molecular weight of 369.08 Da.